How can you rescue an at-risk clinical trial without compromising quality? Delays in clinical research are common and cost pharmaceutical companies exorbitant amounts of money. Four in five clinical trials experience delays, with 94% of trials delayed more than a month—creating a potential financial impact of more than $600,000 daily.1
In this insight brief, Science 37 Chief Delivery Officer, Darcy Forman details how a virtual site (Metasite) is the premier strategy for rescuing an at-risk clinical trial- resulting in faster recruitment and streamlined operations.
1 Article from Drug Development & Drug delivery https://drug-dev.com/cost-of-disrupted-clinical-research-due-to-covid-19-equates-to-10-billion-potential-study-delays/